In addition, to develop prostate cancer immunoprevention and immunotherapy approaches by targeting human SKP2 oncogene and its associate pathways, a prostate-specific SKP2 humanized mouse model is critical. This evidence concerns the gene SKP2 and prostate carcinoma.